PF 915275 structure
|
Common Name | PF 915275 | ||
---|---|---|---|---|
CAS Number | 857290-04-1 | Molecular Weight | 350.394 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | 610.9±65.0 °C at 760 mmHg | |
Molecular Formula | C18H14N4O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 323.3±34.3 °C |
Use of PF 915275PF-915275 is a potent and selective inhibitor of human 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) (Ki < 1 nM) with good preclinical pharmacokinetic properties.IC50 value: < 1 nM (Ki)[2]Target: 11βHSD1in vitro: PF-915275 maintains potency in our cellular assay against human 11βHSD1 (HEK293, EC50 = 5 nM) and is selective against human 11βHSD2 (HEK293, 1.5% inhibition 10 μM). PF-915275 displays only weak affinity for the rodent choline transporter (Ki = 9.6 μM) and the hamster melatonin MT3 receptor (Ki = 9.6 μM) in the Cerep Bioprint screening panel. PF-915275 has good in vitro pharmacokinetic properties. In particular, PF-915275 is categorized as a low clearance compound (liver microsome assays) with high permeability (Caco2 assay). [2]in vivo: As a prelude to in vivo studies with PF-915275, the rat pharmacokinetic properties of this compound were determined. PF-915275 has an excellent pharmacokinetic profile characterized by low clearance, long half-life and good oral bioavailability. [2] |
Name | N-(6-aminopyridin-2-yl)-4-(4-cyanophenyl)benzenesulfonamide |
---|---|
Synonym | More Synonyms |
Description | PF-915275 is a potent and selective inhibitor of human 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) (Ki < 1 nM) with good preclinical pharmacokinetic properties.IC50 value: < 1 nM (Ki)[2]Target: 11βHSD1in vitro: PF-915275 maintains potency in our cellular assay against human 11βHSD1 (HEK293, EC50 = 5 nM) and is selective against human 11βHSD2 (HEK293, 1.5% inhibition 10 μM). PF-915275 displays only weak affinity for the rodent choline transporter (Ki = 9.6 μM) and the hamster melatonin MT3 receptor (Ki = 9.6 μM) in the Cerep Bioprint screening panel. PF-915275 has good in vitro pharmacokinetic properties. In particular, PF-915275 is categorized as a low clearance compound (liver microsome assays) with high permeability (Caco2 assay). [2]in vivo: As a prelude to in vivo studies with PF-915275, the rat pharmacokinetic properties of this compound were determined. PF-915275 has an excellent pharmacokinetic profile characterized by low clearance, long half-life and good oral bioavailability. [2] |
---|---|
Related Catalog | |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 610.9±65.0 °C at 760 mmHg |
Molecular Formula | C18H14N4O2S |
Molecular Weight | 350.394 |
Flash Point | 323.3±34.3 °C |
Exact Mass | 350.083740 |
PSA | 117.25000 |
LogP | 2.06 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.709 |
Storage condition | 2-8℃ |
N-(6-Amino-2-pyridinyl)-4'-cyano-4-biphenylsulfonamide |
[1,1'-Biphenyl]-4-sulfonamide, N-(6-amino-2-pyridinyl)-4'-cyano- |
4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide |
N-(6-aminopyridin-2-yl)-4'-cyanobiphenyl-4-sulfonamide |
PF-915275 |